신경 진단 및 모니터링 기기 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Neurology Diagnostic and Monitoring Devices Market is presumed to reach the market size of nearly USD 24.35 Billion by 2032 from USD 10.66 Billion in 2023 with a CAGR of 9.62% under the study period 2024 - 2032.

Neurology diagnostic and monitoring devices are medical instruments designed for assessing and tracking the functioning of the nervous system. These devices aid healthcare professionals, particularly neurologists, in diagnosing neurological disorders and monitoring patients' neurological conditions over time.

MARKET DYNAMICS

The neurology diagnostic and monitoring devices market is propelled by various factors addressing the increasing prevalence of neurological disorders and technological advancements. The growing incidence of conditions like epilepsy, Alzheimer's, and stroke, particularly among the aging population, fuels the demand for early and accurate diagnostic tools. Continuous technological innovations, including advanced imaging techniques and wearable sensors, enhance the precision and efficiency of neurological assessments. Improved healthcare infrastructure, rising awareness about neurological disorders, and government initiatives further contribute to market growth. Lifestyle-related factors and the adoption of telemedicine drive the demand for devices capable of assessing and monitoring neurological conditions remotely. Investments by healthcare providers, a shift towards patient-centric care, and global awareness campaigns also play pivotal roles in fostering the adoption of neurology diagnostic and monitoring devices. With a dynamic landscape and ongoing advancements, this market continues to evolve, offering increasingly sophisticated tools for the timely diagnosis and effective monitoring of neurological disorders.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of neurology diagnostic and monitoring devices. The growth and trends of neurology diagnostic and monitoring devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the neurology diagnostic and monitoring devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Device Type

• Electroencephalogram (EEG) Systems
• Magnetic Resonance Imaging (Mri) Systems
• Computed Tomography (CT) Scanner
• Position Emission Tomography (Pet) System
• Ultrasound Imaging Systems
• Others

By Indication

• Neurodegenerative Disease
• Epilepsy
• Stroke
• Others

By End-User

• Hospitals And Surgery Centers
• Neurology Centers
• Ambulatory Care Centers
• Diagnostic Laboratories & Imaging Centers
• Research Laboratories & Academic Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Neurology Diagnostic and Monitoring Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Neurology Diagnostic and Monitoring Devices market include GE Healthcare, Neurosoft, Canon Medical Systems Corporation (Canon, Inc.), Fujifilm Holding Corporation, Koninklijke Philips N.V., Siemens Healthineers AG, Shimadzu Corporation, United Imaging Healthcare Co., Ltd, Hologic, Inc., Esaote SpA. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Device Type
  • 3.7.2 Market Attractiveness Analysis By Indication
  • 3.7.3 Market Attractiveness Analysis By End-user
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES MARKET ANALYSIS BY DEVICE TYPE

• 5.1 Overview by Device Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Device Type
• 5.4 Electroencephalogram (EEG) Systems Historic and Forecast Sales by Regions
• 5.5 Magnetic Resonance Imaging (MRI) Systems Historic and Forecast Sales by Regions
• 5.6 Computed Tomography (CT) Scanner Historic and Forecast Sales by Regions
• 5.7 Position Emission Tomography (PET) System Historic and Forecast Sales by Regions
• 5.8 Ultrasound Imaging Systems Historic and Forecast Sales by Regions
• 5.9 Others Historic and Forecast Sales by Regions

6 . GLOBAL NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES MARKET ANALYSIS BY INDICATION

• 6.1 Overview by Indication
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Indication
• 6.4 Neurodegenerative Disease Historic and Forecast Sales by Regions
• 6.5 Epilepsy Historic and Forecast Sales by Regions
• 6.6 Stroke Historic and Forecast Sales by Regions
• 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES MARKET ANALYSIS BY END-USER

• 7.1 Overview by End-user
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-user
• 7.4 Hospitals and Surgery Centers Historic and Forecast Sales by Regions
• 7.5 Neurology Centers Historic and Forecast Sales by Regions
• 7.6 Ambulatory Care Centers Historic and Forecast Sales by Regions
• 7.7 Diagnostic Laboratories & Imaging Centers Historic and Forecast Sales by Regions
• 7.8 Research Laboratories & Academic Institutes Historic and Forecast Sales by Regions

8 . GLOBAL NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES COMPANIES

• 9.1. Neurology Diagnostic And Monitoring Devices Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. GE Healthcare
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Neurosoft
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Canon Medical Systems Corporation (Canon Inc.)
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Fujifilm Holding Corporation
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Koninklijke Philips N.V.
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Siemens Healthineers AG
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Shimadzu Corporation
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. United Imaging Healthcare Co. Ltd
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. Hologic Inc.
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Esaote SpA.
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies